Jorge Andrés Urquijo Méndez
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Jorge Andrés Urquijo Méndez has a total of 24 co-authors. Here are the top co-authors by number of shared publications:
- Alejandro Rico Mendoza
Grupo de Medicina Comunitaria y Salud Colectiva, Universidad El Bosque, Bogotá, Colombia
3 shared publications - Juan Fernando Ramon
Department of Neurosurgery, Fundacion Santa Fe de Bogota, Bogota, Colombia
3 shared publications - Liliana Encinales
Allied Research Society Colombia SAS, Barranquilla, Colombia
3 shared publications - Alexandra Porras-Ramírez
Grupo de Medicina Comunitaria y Salud Colectiva, Universidad El Bosque, Bogotá, Colombia
2 shared publications - Juan Pablo Duque Bolivar
Allied Research Society Colombia SAS, Barranquilla 080001, Colombia
2 shared publications - Oscar Madiedo
Allied Research Society Colombia SAS, Barranquilla, Colombia
2 shared publications
Latest Publications
- 2 September 2026
- Published by Springer Nature in International Journal of Clinical Oncology
- Vol. 31 (10) , 2169-2178
Cost-utility analysis of CAR-T therapy compared to standard of care in patients with relapsed/refractory diffuse large B-cell lymphoma in Colombia, 2025
- 2 September 2026
- Published by Springer Nature in International Journal of Clinical Oncology
- Vol. 31 (10) , 2169-2178
Cost-utility analysis of CAR-T therapy compared to standard of care in patients with relapsed/refractory diffuse large B-cell lymphoma in Colombia, 2025
- Open Access
- 14 August 2026
- Published by MDPI AG in Journal of Fungi
- Vol. 12 (8) , 608
Clinical and Economic Trade-Offs in Antifungal Therapy for Invasive Aspergillosis and Mucormycosis: A Markov Model–Based Analysis
Invasive aspergillosis and mucormycosis are life-threatening fungal infections characterized by high early mortality, substantial toxicity, and intensive healthcare resource utilization. While multiple antifungal therapies are recommended in international guidelines, their comparative clinical and economic value remains uncertain, particularly in resource-limited settings. We developed a hybrid decision tree and Markov model to evaluate antifungal strategies, including liposomal amphotericin B, isavuconazole, voriconazole, posaconazole, and caspofungin, from the perspective of the Colombian healthcare system over a 6-month horizon. Health states included clinical response, treatment failure, toxicity, and death. Outcomes included quality-adjusted life-years (QALYs), costs, incremental cost-effectiveness ratios (ICERs), and net monetary benefit (NMB). Deterministic and probabilistic sensitivity analyses were performed. In invasive aspergillosis, isavuconazole provided a modest incremental benefit over voriconazole (+0.022 QALYs), driven primarily by improved tolerability, at an incremental cost of COP 3.4 million, yielding an ICER of COP 154.5 million/QALY. In mucormycosis, liposomal amphotericin B yielded greater survival benefits (+0.035 QALYs) but at substantially higher costs (ICER: COP 494.3 million/QALY). Across willingness-to-pay thresholds, isavuconazole and voriconazole demonstrated more favorable economic profiles, owing to lower toxicity and reduced hospitalizations. These findings highlight that the clinical–economic value of antifungal therapy is primarily determined by early survival gains, toxicity burden, and front-loaded costs. Strategies minimizing toxicity and hospitalization appear more efficient in constrained health systems, whereas survival-maximizing approaches may be justified in severe disease. This integrated analysis supports context-specific antifungal decision-making in the management of invasive fungal infections.
- 14 August 2026
- Published by MDPI AG in Journal of Fungi
- Vol. 12 (8) , 608
Open AccessClinical and Economic Trade-Offs in Antifungal Therapy for Invasive Aspergillosis and Mucormycosis: A Markov Model–Based Analysis
Invasive aspergillosis and mucormycosis are life-threatening fungal infections characterized by high early mortality, substantial toxicity, and intensive healthcare resource utilization. While multiple antifungal therapies are recommended in international guidelines, their comparative clinical and economic value remains uncertain, particularly in resource-limited settings. We developed a hybrid decision tree and Markov model to evaluate antifungal strategies, including liposomal amphotericin B, isavuconazole, voriconazole, posaconazole, and caspofungin, from the perspective of the Colombian healthcare system over a 6-month horizon. Health states included clinical response, treatment failure, toxicity, and death. Outcomes included quality-adjusted life-years (QALYs), costs, incremental cost-effectiveness ratios (ICERs), and net monetary benefit (NMB). Deterministic and probabilistic sensitivity analyses were performed. In invasive aspergillosis, isavuconazole provided a modest incremental benefit over voriconazole (+0.022 QALYs), driven primarily by improved tolerability, at an incremental cost of COP 3.4 million, yielding an ICER of COP 154.5 million/QALY. In mucormycosis, liposomal amphotericin B yielded greater survival benefits (+0.035 QALYs) but at substantially higher costs (ICER: COP 494.3 million/QALY). Across willingness-to-pay thresholds, isavuconazole and voriconazole demonstrated more favorable economic profiles, owing to lower toxicity and reduced hospitalizations. These findings highlight that the clinical–economic value of antifungal therapy is primarily determined by early survival gains, toxicity burden, and front-loaded costs. Strategies minimizing toxicity and hospitalization appear more efficient in constrained health systems, whereas survival-maximizing approaches may be justified in severe disease. This integrated analysis supports context-specific antifungal decision-making in the management of invasive fungal infections.
- Open Access
- 3 July 2026
- Published by Medical Journals Sweden AB in Journal of Plastic Surgery and Hand Surgery
- Vol. 61, 174-181
Clinical and donor-site outcomes of DIEP versus TRAM flaps in post-mastectomy breast reconstruction: a systematic review and meta-analysis
Background: Autologous breast reconstruction continues to be a cornerstone of post-mastectomy reconstruction, with abdominally based flaps providing reliable aesthetic and functional outcomes. Of these approaches, the deep inferior epigastric perforator (DIEP) flap and the transverse rectus abdominis myocutaneous (TRAM) flap are the most commonly used. However, controversy exists surrounding their relative effectiveness, complication profile, donor-site morbidity, and reported outcomes. Methods: A systematic review and meta-analysis were undertaken according to the Preferred Reporting Items for Systematic Reviews and Meta-Analyses 2020 guidelines. A search was conducted across PubMed, Scopus, Embase, and Web of Science for comparative studies published between January 2000 and December 2025 that assessed DIEP and TRAM flap breast reconstruction. Outcomes included total flap loss, fat necrosis, donor-site morbidity, abdominal wall complications, and patient-reported outcomes. Random-effects meta-analyses were performed employing pooled odds ratios (ORs) and 95% confidence intervals (CIs). Heterogeneity was evaluated by Cochran’s Q and Higgins’ I² statistics. An exploratory network meta-analysis was also performed to compare DIEP with other autologous reconstructive techniques, such as transverse upper gracilis (TUG), transverse myocutaneous gracilis (TMG), profunda artery perforator (PAP), and inferior gluteal artery perforator (IGAP) flaps. Results: Ten studies met the inclusion criteria for the qualitative synthesis, yet five also provided quantitative data that were included in the meta-analysis. Pooled analysis showed no significant difference in fat necrosis between reconstructive techniques (OR: 0.86; 95% CI: 0.54–1.36; I² = 34.6%). Likewise, the total flap loss rates were similar between DIEP and TRAM flaps (OR: 0.79; 95% CI: 0.39–1.61; I² = 7.2%). DIEP reconstruction was consistently associated with fewer donor-site morbidities and significantly better maintenance of abdominal wall health than the TRAM flap. Among exploratory network meta-analysis studies, the TUG flap showed clear superiority in reduced total flap loss, while DIEP flaps ranked favorably in donor-site outcomes and patient satisfaction. Conclusions: DIEP and TRAM flaps have comparable flap survival and overall reconstructive efficacy in post-mastectomy breast reconstruction. DIEP reconstruction appears to offer the best performance in reducing donor-site morbidity while preserving abdominal wall integrity. There was no single reconstruction technique that consistently outperformed all other reconstructive approaches across all outcomes, reinforcing an individualized surgical approach based on patient anatomy, comorbidities, reconstruction goals, and surgeon expertise.
- 3 July 2026
- Published by Medical Journals Sweden AB in Journal of Plastic Surgery and Hand Surgery
- Vol. 61, 174-181
Open AccessClinical and donor-site outcomes of DIEP versus TRAM flaps in post-mastectomy breast reconstruction: a systematic review and meta-analysis
Background: Autologous breast reconstruction continues to be a cornerstone of post-mastectomy reconstruction, with abdominally based flaps providing reliable aesthetic and functional outcomes. Of these approaches, the deep inferior epigastric perforator (DIEP) flap and the transverse rectus abdominis myocutaneous (TRAM) flap are the most commonly used. However, controversy exists surrounding their relative effectiveness, complication profile, donor-site morbidity, and reported outcomes. Methods: A systematic review and meta-analysis were undertaken according to the Preferred Reporting Items for Systematic Reviews and Meta-Analyses 2020 guidelines. A search was conducted across PubMed, Scopus, Embase, and Web of Science for comparative studies published between January 2000 and December 2025 that assessed DIEP and TRAM flap breast reconstruction. Outcomes included total flap loss, fat necrosis, donor-site morbidity, abdominal wall complications, and patient-reported outcomes. Random-effects meta-analyses were performed employing pooled odds ratios (ORs) and 95% confidence intervals (CIs). Heterogeneity was evaluated by Cochran’s Q and Higgins’ I² statistics. An exploratory network meta-analysis was also performed to compare DIEP with other autologous reconstructive techniques, such as transverse upper gracilis (TUG), transverse myocutaneous gracilis (TMG), profunda artery perforator (PAP), and inferior gluteal artery perforator (IGAP) flaps. Results: Ten studies met the inclusion criteria for the qualitative synthesis, yet five also provided quantitative data that were included in the meta-analysis. Pooled analysis showed no significant difference in fat necrosis between reconstructive techniques (OR: 0.86; 95% CI: 0.54–1.36; I² = 34.6%). Likewise, the total flap loss rates were similar between DIEP and TRAM flaps (OR: 0.79; 95% CI: 0.39–1.61; I² = 7.2%). DIEP reconstruction was consistently associated with fewer donor-site morbidities and significantly better maintenance of abdominal wall health than the TRAM flap. Among exploratory network meta-analysis studies, the TUG flap showed clear superiority in reduced total flap loss, while DIEP flaps ranked favorably in donor-site outcomes and patient satisfaction. Conclusions: DIEP and TRAM flaps have comparable flap survival and overall reconstructive efficacy in post-mastectomy breast reconstruction. DIEP reconstruction appears to offer the best performance in reducing donor-site morbidity while preserving abdominal wall integrity. There was no single reconstruction technique that consistently outperformed all other reconstructive approaches across all outcomes, reinforcing an individualized surgical approach based on patient anatomy, comorbidities, reconstruction goals, and surgeon expertise.
- Open Access
- 2 March 2026
- Published by Springer Nature in BMC Cancer
- Vol. 26 (1)
Toxicities associated with CAR-T therapy compared with standard treatments in hematologic malignancies: a systematic review and meta-analysis
Chimeric antigen receptor T-cell (CAR-T) treatment has revolutionized the therapeutic approach for relapsed or refractory hematologic malignancies. But its
- 2 March 2026
- Published by Springer Nature in BMC Cancer
- Vol. 26 (1)
Open AccessToxicities associated with CAR-T therapy compared with standard treatments in hematologic malignancies: a systematic review and meta-analysis
Chimeric antigen receptor T-cell (CAR-T) treatment has revolutionized the therapeutic approach for relapsed or refractory hematologic malignancies. But its
- Open Access
- 3 October 2025
- Published by Universidad el Bosque in Revista Salud Bosque
- Vol. 15 (2)
Identificación de riesgos biomecánicos y trastornos musculoesqueléticos en docentes de una Facultad de Medicina en Bogotá, 2024
Introducción. La docencia implica diversos riesgos biomecánicos debido a posturas prolongadas y movimientos repetitivos, lo que convierte a los profesores en una población propensa a desarrollar trastornos musculoesqueléticos (TME). Este estudio se centró en identificar los principales riesgos en docentes de la Facultad de Medicina de la Universidad El Bosque en el periodo 2024-1; se consideraron variables sociodemográficas y ocupacionales y se indagó sobre la percepción de síntomas musculoesqueléticos. Objetivo. Identificar los principales riesgos biomecánicos y osteomusculares en docentes de la Facultad de Medicina de la Universidad El Bosque. Métodos. Estudio de corte transversal cuantitativo, aplicado a 52 docentes del área Bioclínica de la Facultad de Medicina, mediante la aplicación de una encuesta que incluyó un cuestionario estructurado junto con el Cuestionario Nórdico Estandarizado Kuorinka de 1987. El análisis descriptivo se llevó a cabo con las frecuencias, medidas de tendencia central y dispersión. El análisis comparativo se realizó mediante pruebas estadísticas para variables cuantitativas y cualitativas con el software SPSS y Jamovi. Resultados. Se identificó la prevalencia de síntomas musculoesqueléticos, especialmente en cuello y columna lumbar. Estas molestias se relacionan con las posturas prolongadas sedentes o en bipedestación, así como con cargas horarias elevadas. Se observaron diferencias significativas según el sexo, el índice de masa corporal y el tiempo semanal laborado. Conclusiones. Los principales riesgos biomecánicos y osteomusculares se asociaron con horarios extensos, sedentarismo y posturas sedentes o bípedas mantenidas. La sintomatología musculoesquelética fue más prevalente en mujeres. La actividad física se identificó como un factor protector. Hubo significancia estadística (p = 0,007) entre la postura laboral y la presencia de dolor lumbar. El estudio resalta la necesidad de estrategias ergonómicas y preventivas para reducir la incidencia de TME y mejorar la calidad de vida y el desempeño laboral docente.
- 3 October 2025
- Published by Universidad el Bosque in Revista Salud Bosque
- Vol. 15 (2)
Open AccessIdentificación de riesgos biomecánicos y trastornos musculoesqueléticos en docentes de una Facultad de Medicina en Bogotá, 2024
Introducción. La docencia implica diversos riesgos biomecánicos debido a posturas prolongadas y movimientos repetitivos, lo que convierte a los profesores en una población propensa a desarrollar trastornos musculoesqueléticos (TME). Este estudio se centró en identificar los principales riesgos en docentes de la Facultad de Medicina de la Universidad El Bosque en el periodo 2024-1; se consideraron variables sociodemográficas y ocupacionales y se indagó sobre la percepción de síntomas musculoesqueléticos. Objetivo. Identificar los principales riesgos biomecánicos y osteomusculares en docentes de la Facultad de Medicina de la Universidad El Bosque. Métodos. Estudio de corte transversal cuantitativo, aplicado a 52 docentes del área Bioclínica de la Facultad de Medicina, mediante la aplicación de una encuesta que incluyó un cuestionario estructurado junto con el Cuestionario Nórdico Estandarizado Kuorinka de 1987. El análisis descriptivo se llevó a cabo con las frecuencias, medidas de tendencia central y dispersión. El análisis comparativo se realizó mediante pruebas estadísticas para variables cuantitativas y cualitativas con el software SPSS y Jamovi. Resultados. Se identificó la prevalencia de síntomas musculoesqueléticos, especialmente en cuello y columna lumbar. Estas molestias se relacionan con las posturas prolongadas sedentes o en bipedestación, así como con cargas horarias elevadas. Se observaron diferencias significativas según el sexo, el índice de masa corporal y el tiempo semanal laborado. Conclusiones. Los principales riesgos biomecánicos y osteomusculares se asociaron con horarios extensos, sedentarismo y posturas sedentes o bípedas mantenidas. La sintomatología musculoesquelética fue más prevalente en mujeres. La actividad física se identificó como un factor protector. Hubo significancia estadística (p = 0,007) entre la postura laboral y la presencia de dolor lumbar. El estudio resalta la necesidad de estrategias ergonómicas y preventivas para reducir la incidencia de TME y mejorar la calidad de vida y el desempeño laboral docente.